Miaorong Yu
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 18
- Drug Solubulity and Delivery Systems 6
- Advancements in Transdermal Drug Delivery 4
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 21
- Molecular Medicine top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 7
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 14
- Extracellular vesicles in disease 7
- Lipid Membrane Structure and Behavior 4
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (3 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Miaorong Yu
44 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pharmaceutical Science 551
- Biomaterials 854
- Molecular Medicine 77
- Biomedical Engineering 673
- Molecular Biology 842
Countries citing papers authored by Miaorong Yu
This map shows the geographic impact of Miaorong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaorong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaorong Yu more than expected).
Fields of papers citing papers by Miaorong Yu
This network shows the impact of papers produced by Miaorong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaorong Yu. The network helps show where Miaorong Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miaorong Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 10 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomesbreakdown → | 2024 | 70 |
| 6 | 2023 | 5 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 56 | |
| 9 | 2022 | 34 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 40 | |
| 12 | 2020 | 47 | |
| 13 | 2020 | 41 | |
| 14 | 2020 | 37 | |
| 15 | 2020 | 53 | |
| 16 | 2019 | 12 | |
| 17 | 2019 | 81 | |
| 18 | 2019 | 188 | |
| 19 | 2019 | 73 | |
| 20 | 2019 | 116 |
About Miaorong Yu
Miaorong Yu is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), Advanced Drug Delivery Systems (18 papers), RNA Interference and Gene Delivery (14 papers), Extracellular vesicles in disease (7 papers), Nanoplatforms for cancer theranostics (7 papers), Drug Solubulity and Delivery Systems (6 papers), Advancements in Transdermal Drug Delivery (4 papers) and Lipid Membrane Structure and Behavior (4 papers). The work is most often cited by research in Pharmaceutical Science (551 citations), Biomaterials (854 citations) and Molecular Medicine (77 citations). Miaorong Yu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Yong Gan, Chunliu Zhu, Shiyan Guo, Yiwei Yang, Xinghua Shi, Di Nie, Huajian Gao, Jiuling Wang, Aohua Wang and Zhuo Dai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.